Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Am Soc Clin Oncol Educ Book. 2021 Jun;41:e13-e19. doi: 10.1200/EDBK_100029.
The COVID-19 pandemic and the simultaneous increased focus on structural racism and racial/ethnic disparities across the United States have shed light on glaring inequities in U.S. health care, both in oncology and more generally. In this article, we describe how, through the lens of fundamental ethical principles, an ethical imperative exists for the oncology community to overcome these inequities in cancer care, research, and the oncology workforce. We first explain why this is an ethical imperative, centering the discussion on lessons learned during 2020. We continue by describing ongoing equity-focused efforts by ASCO and other related professional medical organizations. We end with a call to action-all members of the oncology community have an ethical responsibility to take steps to address inequities in their clinical and academic work-and with guidance to practicing oncologists looking to optimize equity in their research and clinical practice.
新冠疫情以及美国对结构性种族主义和种族/民族差异的同时关注,凸显了美国医疗保健系统在肿瘤学和更广泛领域中存在的明显不平等现象。在本文中,我们通过基本伦理原则的视角描述了为什么肿瘤学界在癌症护理、研究和肿瘤学劳动力方面克服这些不平等现象具有道德必要性。我们首先解释了为什么这是一项道德义务,将讨论的重点放在 2020 年期间吸取的经验教训上。接着,我们描述了 ASCO 及其他相关专业医学组织正在进行的以公平为重点的努力。最后,我们呼吁行动——肿瘤学界的所有成员都有道德责任采取措施,解决其临床和学术工作中的不平等问题,并为希望在研究和临床实践中优化公平性的肿瘤医生提供指导。